Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.
Oberbauer R, Segoloni G, Campistol JM, Kreis H, Mota A, Lawen J, Russ G, Grinyó JM, Stallone G, Hartmann A, Pinto JR, Chapman J, Burke JT, Brault Y, Neylan JF; Rapamune Maintenance Regimen Study Group. Oberbauer R, et al. Among authors: brault y. Transpl Int. 2005 Jan;18(1):22-8. doi: 10.1111/j.1432-2277.2004.00052.x. Transpl Int. 2005. PMID: 15612979 Free article. Clinical Trial.
Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years.
Mota A, Arias M, Taskinen EI, Paavonen T, Brault Y, Legendre C, Claesson K, Castagneto M, Campistol JM, Hutchison B, Burke JT, Yilmaz S, Häyry P, Neylan JF; Rapamune Maintenance Regimen Trial. Mota A, et al. Among authors: brault y. Am J Transplant. 2004 Jun;4(6):953-61. doi: 10.1111/j.1600-6143.2004.00446.x. Am J Transplant. 2004. PMID: 15147430 Free article. Clinical Trial.
Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years.
Legendre C, Brault Y, Morales JM, Oberbauer R, Altieri P, Riad H, Mahony J, Messina M, Pussell B, Martínez JG, Lelong M, Burke JT, Neylan JF; Rapamune Maintenance Regimen Study Group. Legendre C, et al. Among authors: brault y. Clin Transplant. 2007 May-Jun;21(3):330-6. doi: 10.1111/j.1399-0012.2007.00645.x. Clin Transplant. 2007. PMID: 17488381 Clinical Trial.
Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function.
Friend P, Russ G, Oberbauer R, Murgia MG, Tufveson G, Chapman J, Blancho G, Mota A, Grandaliano G, Campistol JM, Brault Y, Burke JT; Rapamune Maintenance Regimen (RMR) Study Group. Friend P, et al. Among authors: brault y. Transpl Int. 2007 Sep;20(9):754-60. doi: 10.1111/j.1432-2277.2007.00506.x. Epub 2007 Jun 12. Transpl Int. 2007. PMID: 17565578 Free article. Clinical Trial.
Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporine.
Morales JM, Hartmann A, Walker R, Arns W, Senatorski G, Grinyó JM, Shoker A, Wilczek H, Jamieson NV, Lelong M, Brault Y, Burke JT, Scarola JA; Rapamune Maintenance Regimen Study Group. Morales JM, et al. Among authors: brault y. Transplant Proc. 2009 Jul-Aug;41(6):2339-44. doi: 10.1016/j.transproceed.2009.05.009. Transplant Proc. 2009. PMID: 19715914
Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.
Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF; Rapamune Maintenance Regimen Trial. Kreis H, et al. Among authors: brault y. J Am Soc Nephrol. 2004 Mar;15(3):809-17. doi: 10.1097/01.asn.0000113248.59077.76. J Am Soc Nephrol. 2004. PMID: 14978184 Clinical Trial.
43 results